Victoza is FDA-approved for the treatment of type 2 diabetes, while Saxenda is FDA-approved for the treatment of obesity
According to incomplete statistics, sales of Novo Nordisk's semaglutide have been soaring year after year, with 2023 sales surpassing $21.2 billion, making it the first GLP-1 drug to join the "billion-dollar club." Its market position is quickly catching up with Merck's Keytruda, and it has the potential to become the next "blockbuster" drug
GIP receptor GIP helps the body use insulin more effectively after meals, allowing blood sugar levels to settle more smoothly
Tirzepatide, with its dual GIP/GLP-1 action, may offer even stronger glycemic benefits, though this remains to be confirmed in a postpartum-specific population
Innovations introduced longer-acting formulations: semaglutide (novel peptide with fatty acid modifications) enabled once-weekly dosing and was first approved as Ozempic (T2D, 2017) and then as Wegovy (obesity, 2021)
Best Practices for Storing Your PlexusDx Semaglutide Injections Store your compounded semaglutide injection in the original container provided by your licensed 503A pharmacy